| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.17▼ | 1.17▼ | 1.17▼ | 1.18▼ | 1.17▼ |
| MA10 | 1.17▼ | 1.17▼ | 1.17▼ | 1.22▼ | 1.31▼ |
| MA20 | 1.17▼ | 1.18▼ | 1.17▼ | 1.20▼ | 1.07▲ |
| MA50 | 1.18▼ | 1.21▼ | 1.22▼ | 1.31▼ | 1.13▲ |
| MA100 | 1.22▼ | 1.24▼ | 1.22▼ | 1.04▲ | N/A |
| MA200 | 1.23▼ | 1.20▼ | 1.32▼ | 1.06▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.001▲ | 0.001▲ | -0.004▼ | 0.010▲ |
| RSI | 39.746▼ | 41.362▼ | 40.921▼ | 44.373▼ | 51.203▲ |
| STOCH | 56.667 | 17.778▼ | 27.778 | 22.938 | 20.475 |
| WILL %R | -75.000▼ | -83.333▼ | -83.333▼ | -80.769▼ | -73.930 |
| CCI | -166.377▼ | -142.857▼ | -153.892▼ | -89.822 | -21.154 |
| ▲ GAP | $KAPA Open Gap Up %2 | Set Alert |
|
Monday, October 20, 2025 07:13 PM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today presents on the positive interim efficacy data from its ongoing ...
|
|
Monday, October 20, 2025 05:18 AM
Interim efficacy analysis highlights potential value of combination therapy of ENV-105 and apalutamide following positive safety data Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopha ...
|
|
Tuesday, October 07, 2025 06:10 AM
Investing.com -- Kairos Pharma, Ltd. (NYSE American:KAPA) stock gained 4.1% in Tuesday’s premarket trading after the clinical-stage biopharmaceutical company announced its selection to present at the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/10/25 | 1.20 | 1.21 | 1.15 | 1.16 | 360,260 |
| 20/10/25 | 1.20 | 1.218 | 1.15 | 1.17 | 390,700 |
| 17/10/25 | 1.19 | 1.20 | 1.15 | 1.16 | 245,783 |
| 16/10/25 | 1.25 | 1.28 | 1.16 | 1.17 | 332,682 |
| 15/10/25 | 1.31 | 1.31 | 1.22 | 1.25 | 395,424 |
| 14/10/25 | 1.22 | 1.30 | 1.2101 | 1.29 | 392,673 |
| 13/10/25 | 1.20 | 1.26 | 1.20 | 1.21 | 181,739 |
| 10/10/25 | 1.32 | 1.32 | 1.16 | 1.16 | 631,181 |
| 09/10/25 | 1.34 | 1.37 | 1.23 | 1.32 | 526,100 |
| 08/10/25 | 1.27 | 1.34 | 1.2413 | 1.31 | 437,116 |
|
|
||||
|
|
||||
|
|